TriCert Investment Counsel Inc.’s Amgen AMGN Stock Holding History

TriCert Investment Counsel Inc.’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.7M	Buy	+57,233	New	+$19.6M	1.93%	19

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TriCert Investment Counsel Inc.'s AMGN Position: Q2 2026 in Review

TriCert Investment Counsel Inc. opened a new position in Amgen (AMGN) in Q2 2026: 57,233 shares worth $20.7M. The stake represents 1.93% of the portfolio and ranks #19 among its holdings.

2,223 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

TriCert Investment Counsel Inc. held 57,233 shares of Amgen worth $20.7M as of Q2 2026.
Amgen was a new TriCert Investment Counsel Inc. position in Q2 2026.
Amgen made up 1.93% of TriCert Investment Counsel Inc.'s portfolio in Q2 2026, its #19 holding.
2,223 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on TriCert Investment Counsel Inc.'s 13F filing for Q2 2026, filed 10 Aug 2026.